Publications by authors named "Ariel Kredentser"
Objective: The purpose of this study was to evaluate whether the combination of cefazolin or a second-generation cephalosporin plus metronidazole is associated with a reduced risk of surgical site infection in women undergoing hysterectomy for gynecologic cancer compared to using cefazolin or a second-generation cephalosporin alone.
Methods: This was a retrospective cohort study of patients who underwent hysterectomy at a single institution between January 2020 and June 2022. The primary outcome was surgical site infection.
Endometrial cancer in a transgender male: A rare case and review of the literature.
Gynecol Oncol Rep
June 2023
Article Synopsis
- Endometrial cancer is the most common gynecological cancer in the U.S., but its prevalence in transgender men remains largely unknown, with only four documented cases.
- A 36-year-old transgender man, assigned female at birth, was diagnosed with early-stage endometrial cancer after experiencing vaginal bleeding, despite being on testosterone therapy for five years.
- This case highlights that transgender men can develop endometrial carcinoma and emphasizes the importance of routine gynecological care for this population.
Establishing patient-derived organoids from human endometrial cancer and normal endometrium.
Front Endocrinol (Lausanne)
May 2023
Article Synopsis
- Endometrial cancer is the most common type of cancer in women's reproductive organs in the U.S., and it's becoming more common and deadly.
- Scientists are having trouble studying this cancer because current methods don't accurately show how it behaves, but patient-derived organoids (tiny lab-grown copies of tumors) can help.
- Researchers created organoids from cancer samples of 10 patients, which can be stored and used to learn more about the cancer and test how it responds to different treatments.